Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-07-06T00:00:15.490Z Has data issue: false hasContentIssue false

Membrane lipid rafts are required for D2 dopamine receptor signaling

Published online by Cambridge University Press:  16 April 2020

D. Sibley
Affiliation:
Molecular Neuropharmacology Section, National Institutes of Health/NINDS, Bethesda, MD, USA
L. Hazelwood
Affiliation:
Molecular Neuropharmacology Section, National Institutes of Health/NINDS, Bethesda, MD, USA
R. Roof
Affiliation:
Molecular Neuropharmacology Section, National Institutes of Health/NINDS, Bethesda, MD, USA
R.B. Free
Affiliation:
Molecular Neuropharmacology Section, National Institutes of Health/NINDS, Bethesda, MD, USA
Y. Han
Affiliation:
Center for Molecular Recognition, Columbia University, New York, NY, USA
J. Javitch
Affiliation:
Center for Molecular Recognition, Columbia University, New York, NY, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Lipid rafts are specialized membrane microdomains enriched in cholesterol and sphingolipids and are important in the organization of receptor-protein complexes and the regulation of signaling.

Objective/aims

Given the emerging significance of lipids with respect to receptor structure and activation, we investigated the role of lipid rafts and membrane cholesterol on D2 dopamine receptor (DAR) signaling. As the D2 DAR is the molecular target for all antipsychotic drugs, more information about its signaling may help refine therapeutics for schizophrenia.

Methods

D2 DAR constructs were expressed in HEK293T cells. Sucrose density fractionation resolved lipid rafts from other membrane components. Methyl-β-cyclodextrin (MCD) was used to deplete membrane cholesterol and to disrupt lipid rafts.

Results

Detergent solubilization followed by sucrose gradient centrifugation resolved lipid rafts from heavier membrane fractions. The D2 DAR was equally distributed amongst both the lipid raft and heavier membrane fractions. Pretreatment with MCD, however, eliminated both lipid raft markers and the D2 DAR from lipid raft fractions, although the receptor was still found in heavier membrane fractions. We also found that MCD treatment abolished D2 DAR-mediated inhibition of cAMP accumulation. In contrast D1 DAR-stimulated cAMP accumulation was unaffected by MCD treatment.

Conclusions

Our current results show that the D2 DAR is distributed in multiple membrane microdomains, including cholesterol-rich lipid rafts. We found that extraction of cholesterol disrupted lipid rafts and also an eliminated D2 DAR-mediated signaling. Thus, we hypothesize that lipid rafts are critical for D2 DAR signaling to occur.

Type
P02-314
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.